SEC CIK 1055922
ROGERS STEVEN A
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| Dview stock → | 54,907.36 | 2012-02-01 |
Position History — D
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — D
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2012-02-01 | Tax withholding | 1,667 | $50.42 | 54,907.36 |
| 2012-02-01 | Grant / award | 3,471 | $0.00 | 56,574.36 |
| 2011-04-01 | Tax withholding | 1,381 | $44.70 | 52,126.81 |
| 2011-02-01 | Grant / award | 4,020 | $0.00 | 53,148.2 |
| 2010-04-03 | Tax withholding | 1,260 | $41.83 | 48,110.39 |
| 2010-02-01 | Grant / award | 4,672 | $0.00 | 49,015.08 |
| 2009-05-11 | Tax withholding | 809 | $31.87 | 43,335 |
| 2009-04-01 | Tax withholding | 1,621 | $30.99 | 44,144 |
| 2009-03-04 | Grant / award | 1,000 | $28.23 | 45,435 |
| 2009-02-02 | Grant / award | 4,975 | $0.00 | 44,435 |
| 2008-04-01 | Grant / award | 4,286 | $0.00 | 38,794 |
| 2008-02-24 | Tax withholding | 1,798 | $42.27 | 34,285 |
| 2007-11-05 | Option exercise (derivative) | 14,600 | $0.00 | 0 |
| 2007-11-05 | Open-market sale | 14,600 | $92.00 | 17,963 |
| 2007-11-05 | Option exercise | 14,600 | $59.96 | 32,563 |
| 2007-11-01 | Option exercise (derivative) | 5,400 | $0.00 | 14,600 |
| 2007-11-01 | Option exercise | 5,400 | $59.96 | 23,363 |
| 2007-11-01 | Open-market sale | 5,400 | $92.00 | 17,963 |
| 2007-10-29 | Option exercise (derivative) | 20,000 | $0.00 | 0 |
| 2007-10-29 | Open-market sale | 19,000 | $90.00 | 17,963 |
| 2007-10-29 | Option exercise | 20,000 | $59.96 | 36,963 |
| 2007-06-11 | I | 1,195 | $83.67 | 2,403 |
| 2007-05-11 | Tax withholding | 404 | $89.75 | 16,824 |
| 2007-04-03 | Grant / award | 1,956 | $0.00 | 17,170 |
| 2006-06-05 | Open-market buy | 231 | $74.24 | 14,877 |
| 2006-03-31 | Grant / award | 2,517 | $0.00 | 14,646 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.